InspireMD
NSPR | NASDAQ
$0.60
-$0.04 (-6.85%)
At close: Nov 16, 2026, 4:00 PM ET
$0.61
+$0.01 (+2.00%)
After-hours:
Nov 16, 2026, 5:49 PM ET
InspireMD Company Profile
Company profile explainedCompany Profile
InspireMD, Inc., an Israel-based medical technology company established in 2005, specializes in creating and commercializing advanced medical devices. Its core expertise lies in the proprietary MicroNet stent platform technology, engineered to address various vascular and coronary diseases. The company's offerings, distributed through a network of local partners, reach markets across Europe, Latin America, the Middle East, and Asia Pacific. Key products include the CGuard carotid embolic prevention system, specifically designed for carotid artery procedures, and the MGuard Prime embolic protection systems. The MGuard Prime systems are crucial for patients experiencing acute coronary syndromes, notably acute myocardial infarction, and those undergoing saphenous vein graft coronary interventions or bypass surgery. InspireMD is also developing PVGuard, an innovative solution combining a MicroNet mesh sleeve with a self-expandable stent, aimed at peripheral vascular applications.
Key Executives
| Name | Position |
|---|---|
| Marvin L. Slosman | President, Chief Executive Officer & Director |
| Amir Kohen | Executive Vice President of Finance & Regional Manager |
| Donna DeChant | Vice President of Human Resources & Organizational Development |
| Kathleen Kennedy | Senior Vice President of Global Sales & Marketing |
| Michael A. Lawless | CFO, Secretary & Treasurer |
| Pete Ligotti | Executive Vice President & GM of North America |
| Peter A. Soukas | Chief Medical Officer |
| Sol J. Barer | Special Advisor to the Board |
| Sonali Dewan | Senior Vice President of Regulatory & Medical Affairs and Quality Assurance |
| Vince Turturro | Senior Vice President of Global Operations & Engineering |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Sep 23, 2026 | 4 | Filing |
| Sep 23, 2026 | 4 | Filing |
| Sep 23, 2026 | 4 | Filing |
| Sep 21, 2026 | 8-K | Current Report |
| Aug 17, 2026 | 8-K | Current Report |
| Aug 14, 2026 | 10-Q | Quarterly Report |
| Jul 29, 2026 | 8-K | Current Report |
| Jul 23, 2026 | 8-K | Current Report |
| Jul 02, 2026 | 8-K | Current Report |
| Jun 11, 2026 | 8-K | Current Report |
InspireMD
| Country | United States |
| IPO Date | Apr 12, 2011 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 127 |
| CEO | Marvin L. Slosman |
Contact Details
6303 Waterford District Drive Miami,
Florida 33126 United States
Stock Details
| Ticker Symbol | NSPR |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001433607 |
| CUSIP Number | 45779A846 |
| ISIN Number | US45779A8466 |
| SIC Code | 3841 |
Add to Watchlist
Select watchlists to add or remove NSPR